Trademark Details For DEXOPRAZOL (Serial Number 86659829)

  •  Home
  •  Print
DEXOPRAZOL
0
0
0
0
Basic Information
Serial Number  United States - USPTO 86659829
Registration Number 5167101
Mark
DEXOPRAZOL
Filing Date Jun-11-2015
Status
Dead  
CANCELLED - .. (710)
CANCELLED - SECTION 8
Attorney Name
TTAB
0


  • LIPTIS PHARMACEUTICALS USA, INC.


005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Sec. 8 - Entire Registration

First Use: Sep-01-2016

First Use in Commerce: Sep-01-2016





Correspondences

NameBRIAN A. BLOOM
AddressMoritt Hock & Hamroff Llp 400 Garden City Plz Garden City, NY 11530-3322

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jun-15-2015NEW APPLICATION ENTERED   NWAPI
Jun-16-2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Sep-17-2015ASSIGNED TO EXAMINER   DOCKD
Sep-18-2015APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Oct-07-2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Oct-27-2015PUBLISHED FOR OPPOSITION   PUBOA
Oct-27-2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Dec-22-2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Jun-21-2016SOU TEAS EXTENSION RECEIVED   EEXTI
Jun-21-2016SOU EXTENSION 1 FILED   EXT1S
Jun-21-2016SOU EXTENSION 1 GRANTED   EX1GS
Jun-23-2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Dec-22-2016TEAS STATEMENT OF USE RECEIVED   EISUI
Jan-17-2017CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Dec-22-2016USE AMENDMENT FILED   IUAFS
Jan-23-2017STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Feb-14-2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Feb-15-2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Mar-21-2017REGISTERED-PRINCIPAL REGISTER   R.PRA
Mar-21-2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Oct-06-2023CANCELLED SEC. 8 (6-YR)   C8..O